FDANonrulemakingFDA-2019-D-4447

Who commented on this docket

Transdermal and Topical Delivery Systems - Product Development and Quality Considerations; Draft Guidance for Industry; Availability

1 organizations filed 1 public comment on Transdermal and Topical Delivery Systems - Product Development and Quality Considerations; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 2351d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 2351d ago

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.